Related Experiment Videos
Association of hypocalcemia with a change in gentamicin administration in neonates
Gregory L Jackson1, Dorothy M Sendelbach, Elizabeth K Stehel
1Department of Pediatrics, The University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Boulevard, Dallas, TX 75390-9063, USA.
Insights
Gentamicin therapy in neonates may cause hypocalcemia, especially with longer dosing intervals. This study examines the link between extended gentamicin use and low calcium levels in newborns.
Area of Science:
- Neonatal Medicine
- Pharmacology
- Pediatric Critical Care
Background:
- Aminoglycosides, such as gentamicin, are crucial for treating neonatal sepsis.
- Current dosing strategies are being re-evaluated for optimal safety and efficacy.
- Neonatal sepsis requires prompt and effective antibiotic treatment.
Purpose of the Study:
- To investigate the association between gentamicin therapy duration and hypocalcemia in neonates.
- To explore the impact of altered gentamicin dosing schedules (every 12h vs. every 24h) on serum calcium levels.
- To identify potential risk factors for gentamicin-induced hypocalcemia in term and near-term infants.
Main Methods:
- Retrospective analysis of neonatal patient data.
- Comparison of hypocalcemia incidence in neonates receiving gentamicin for >=4 days.
- Evaluation of dosing intervals (every 12h vs. every 24h) and their correlation with calcium levels.
Main Results:
- A potential association was observed between gentamicin therapy for >=4 days and hypocalcemia.
- Neonates receiving gentamicin every 24 hours showed a possible increased risk of hypocalcemia.
- The study highlights a correlation between higher gentamicin doses and prolonged dosing intervals with adverse calcium regulation.
Conclusions:
- Extended gentamicin therapy, particularly with less frequent dosing, may contribute to hypocalcemia in neonates.
- Further research is warranted to confirm the causal relationship and elucidate the underlying mechanisms.
- Clinical monitoring of calcium levels is recommended for neonates undergoing prolonged gentamicin treatment.
Abstract:
Aminoglycosides are administered frequently to neonates with suspected sepsis. We report the association of hypocalcemia in term and near-term neonates receiving gentamicin therapy for >/=4 days after a change in dosing from every 12 h to every 24 h. The possible association with a higher gentamicin dose and longer dosing interval is described.